Risk assess ambulatory transplant pathways and reflect this in the quality management plans and standard operating procedures in line with NICE's guideline on haematological cancers and Joint Accreditation Committee International Society for Cell and Gene Therapy (ISCT)-Europe and European Society for Blood and Marrow Transplantation (JACIE) standards. [Amended September 2023]
This recommendation has been deleted. [September 2023]
This recommendation has been deleted. [September 2023]
This recommendation has been deleted. [September 2023]
For patients having allogeneic haemopoietic stem cell transplantation (HSCT), identify a back-up donor or cord blood unit where available in case there are problems with harvesting or transport. [Amended September 2023]
This recommendation has been deleted. [September 2023]
This recommendation has been deleted. [September 2023]
This recommendation has been deleted. [September 2023]
This recommendation has been deleted. [September 2023]
Ensure that healthcare professionals are aware of and follow the local policies of their transplant unit for returning to work after COVID-19. [Amended July 2022]